SCHEMBL4907650

SCHEMBL4907650

COc1ccccc1N1CCN(CCCCN(C(N)=O)c2cc3ccc(F)cn3n2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 8/20 0.50
DRD3 P35462 8/20 0.50
DRD4 P21917 7/20 0.50
HTR1A P08908 6/20 0.50
ADRA1A P35348 5/20 0.50
DRD1 P21728 5/20 0.50
HTR2A P28223 5/20 0.50
ALDH1A1 P00352 4/20 0.50
ADRA1D P25100 4/20 0.50
ADRA1B P35368 4/20 0.50
HTR2C P28335 3/20 0.50
HTR2B P41595 3/20 0.50
POLB P06746 1/20 0.50
DRD5 P21918 1/20 0.50
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
KDM4E B2RXH2 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
MEN1 O00255 1/20 0.49
BLM P54132 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4907577 0.99 DRD2 (0.51) DRD2DRD3DRD4HTR1AADRA1A
SCHEMBL4917959 0.91 DRD2 (0.49) DRD2DRD3DRD4HTR1AADRA1A
SCHEMBL4913177 0.91 DRD2 (0.50) DRD2DRD3DRD4HTR1AADRA1A
SCHEMBL4914339 0.90 DRD2 (0.50) DRD2DRD3DRD4HTR1AADRA1A
SCHEMBL4915621 0.90 DRD2 (0.50) DRD2DRD3DRD4HTR1AADRA1A
SCHEMBL4918006 0.85 DRD2 (0.49) DRD2DRD3DRD4HTR1AADRA1A
SCHEMBL4917921 0.85 DRD4 (0.60) DRD2DRD3DRD4HTR1AADRA1A
SCHEMBL4916997 0.85 DRD2 (0.54) DRD2DRD3DRD4HTR1AADRA1A
SCHEMBL4911987 0.85 DRD2 (0.49) DRD2DRD3DRD4HTR1AADRA1A
SCHEMBL4918170 0.85 DRD4 (0.59) DRD2DRD3DRD4HTR1AADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778685-B1 INDOLIZINE CARBOXAMIDES AND THE AZA AND DIAZA DERIVATIVES THEREOF SANOL ARZNEI SCHWARZ GMBH (DE) 2008-03-26 EP claimed
US-20080051409-A1 Indolizine Carboxamides and Aza and Diaza Derivatives Thereof SCHWARZ PHARMA AG (DE) 2008-02-28 US claimed
EP-1778685-B1 INDOLIZINE CARBOXAMIDES AND THE AZA AND DIAZA DERIVATIVES THEREOF SANOL ARZNEI SCHWARZ GMBH (DE) 2008-03-26 EP disclosed
US-20080051409-A1 Indolizine Carboxamides and Aza and Diaza Derivatives Thereof SCHWARZ PHARMA AG (DE) 2008-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051409-A1 Indolizine Carboxamides and Aza and Diaza Derivatives Thereof GRIN2A, GRIN2C, GRIN1 DRD2 248/4885DRD3 474/4885DRD4 166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.